National audienceIn accordance with the United States National Research Council [NRC (2007)] recommendations for research into new pathways likely to help determine the mode of action of the environmental substances responsible for their toxicity, the objective of this work is to assess the possibility of applying these recommendations and to assess how their consideration might lead to revising or completing current practices for hazard identification during health risk assessments. Better knowledge of mechanisms of action, at both the cellular and molecular levels, should enable us to define the early response associated with a battery of (in vitro) tests and with some types of biomarkers. In particular, the development of models such as ...
The March 2013 European Directive banned testing cosmetic ingredients on animals and new in vitro te...
Liver damage has a variety of causes. Due to the role of liver in the metabolism of xenobiotics, liv...
Hepatotoxicity remains a significant cause for drug failures during clinical trials. This is due, in...
Hepatotoxicity is one of the most frequently observed adverse effects resulting from exposure to a x...
Hepatotoxicity is one of the most frequently observed adverse effects resulting from exposure to a x...
Increasing numbers of chemicals are registered at federal agencies of which most of them have little...
Hepatotoxicity is a serious adverse health effect caused by drugs and other chemical toxins generall...
Currently the assessment of risk to human health from exposure to manufactured chemicals is mainly b...
The liver is one of the five most common target organs of toxicity, both during acute and chronic (r...
The liver is a heterogeneous organ with many vital functions, including metabolism of pharmaceutical...
Xenobiotics or their metabolite(s) can be electrophilic or free radicals that elicit a variety of ch...
Xenobiotic safety assessment is an area that impacts a multitude of different industry sectors such ...
International audienceDrug administration is not without risk, particularly in the context of an und...
Introduction The liver is an important target for drug-induced toxicities. Early detection of hepato...
A significant challenge in toxicology is the ‘too many chemicals’ problem. Human beings and environm...
The March 2013 European Directive banned testing cosmetic ingredients on animals and new in vitro te...
Liver damage has a variety of causes. Due to the role of liver in the metabolism of xenobiotics, liv...
Hepatotoxicity remains a significant cause for drug failures during clinical trials. This is due, in...
Hepatotoxicity is one of the most frequently observed adverse effects resulting from exposure to a x...
Hepatotoxicity is one of the most frequently observed adverse effects resulting from exposure to a x...
Increasing numbers of chemicals are registered at federal agencies of which most of them have little...
Hepatotoxicity is a serious adverse health effect caused by drugs and other chemical toxins generall...
Currently the assessment of risk to human health from exposure to manufactured chemicals is mainly b...
The liver is one of the five most common target organs of toxicity, both during acute and chronic (r...
The liver is a heterogeneous organ with many vital functions, including metabolism of pharmaceutical...
Xenobiotics or their metabolite(s) can be electrophilic or free radicals that elicit a variety of ch...
Xenobiotic safety assessment is an area that impacts a multitude of different industry sectors such ...
International audienceDrug administration is not without risk, particularly in the context of an und...
Introduction The liver is an important target for drug-induced toxicities. Early detection of hepato...
A significant challenge in toxicology is the ‘too many chemicals’ problem. Human beings and environm...
The March 2013 European Directive banned testing cosmetic ingredients on animals and new in vitro te...
Liver damage has a variety of causes. Due to the role of liver in the metabolism of xenobiotics, liv...
Hepatotoxicity remains a significant cause for drug failures during clinical trials. This is due, in...